Ebewe Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for EBEWE PHARMA
EBEWE PHARMA has three approved drugs.
Drugs and US Patents for Ebewe Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ebewe Pharma | EPIRUBICIN HYDROCHLORIDE | epirubicin hydrochloride | INJECTABLE;INJECTION | 065339-002 | Dec 22, 2009 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Ebewe Pharma | VINORELBINE TARTRATE | vinorelbine tartrate | INJECTABLE;INJECTION | 078408-001 | Feb 13, 2008 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Ebewe Pharma | FLUOROURACIL | fluorouracil | INJECTABLE;INJECTION | 040772-001 | Aug 11, 2008 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

